Safety immunogenicity Haemophilus influenzae type conjugate vaccine high risk American Indian population erratum Pediatr Infect Dis May safety immunogenicity Haemophilus influenzae type polysaccharide conjugate vaccine outer membrane protein complex Neisseria meningitidis Hib-OMP Apache Navajo infants children dose Hib-OMP children months age Ninety-two infants weeks old dose Hib-OMP time enrollment subsequent dose vaccine months third dose months age children protective antibody concentration microgram/ml month postvaccination infants Apaches Navajos protective anti-PRP antibody concentration prevaccination month post vaccination Apaches Navajos protective anti-PRP antibody concentrations month second immunization Apaches Navajos protective anti-PRP concentrations infants third booster immunization protective anti-PRP antibody titers booster immunization month booster immunization infants protective concentrations anti-PRP antibody Hib-OMP safe immunogenic Apache Navajo infants children 